Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

Price & Volume
Recent Price$0.82
52 Week High$1.89
52 Week Low$0.71
Average Volume (30 days)219.05K
Share Related Items
Market Cap$71.69M
Shares Outstanding88.50M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-10,000.0%
Financial Strength
Quick Ratio (MRQ)12.0
Current Ratio (MRQ)12.4
LT Debt/Capital (MRQ)3%
Total Debt/Equity (MRQ)3%
Valuation Ratios
Price/Earnings (TTM)(81.00)
Price/Sales (TTM)4.44
Price/Book (MRQ)1.69
Price/Cash Flow (TTM)--
Per Share Data
Earnings (TTM)($0.01)
Sales (TTM)$0.18
Book Value (MRQ)$0.48
Cash Flow (TTM)($0.05)
Cash (MRQ)$0.48
Management Effectiveness
Return on Equity (TTM)-1.8%
Return on Assets (TTM)-1.5%
Return on Investment (TTM)-1.6%
Gross Margin (TTM)62.3%
EBIT Margin (TTM)-3.7%
Profit Margin (TTM)37.5%